Submit your email to push it up the queue
Miltenyi Biotec Inc., a leading player in the life sciences industry, is headquartered in the United States and operates extensively across Europe and Asia. Founded in 1989, the company has established itself as a pioneer in the development of innovative tools and technologies for biomedical research and cellular therapy. Miltenyi Biotec is renowned for its core products, including cell separation systems, flow cytometry solutions, and gene editing technologies, which are distinguished by their precision and reliability. The company’s commitment to advancing scientific research has positioned it as a trusted partner for researchers and clinicians worldwide. With a strong market presence and a reputation for excellence, Miltenyi Biotec continues to drive advancements in the fields of immunology, oncology, and regenerative medicine, contributing significantly to the evolution of modern healthcare solutions.
How does Miltenyi Biotec Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Miltenyi Biotec Inc.'s score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Miltenyi Biotec Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported emissions figures. The company is a current subsidiary of Miltenyi Biotec GmbH, which may influence its climate commitments and initiatives. While there are no documented reduction targets or climate pledges from Miltenyi Biotec Inc. itself, it is important to note that any potential commitments or targets may be inherited from its parent company, Miltenyi Biotec GmbH. However, specific details regarding these initiatives or emissions data have not been provided. As a part of the broader industry context, Miltenyi Biotec Inc. is expected to align with standard climate practices, potentially engaging in initiatives such as the Science Based Targets initiative (SBTi) or other sustainability frameworks, although no specific commitments have been disclosed at this time. In summary, while Miltenyi Biotec Inc. does not currently report emissions data or reduction targets, its affiliation with Miltenyi Biotec GmbH may play a role in shaping its future climate strategies.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Miltenyi Biotec Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.